2.57
Heartbeam Inc stock is traded at $2.57, with a volume of 853.86K.
It is up +7.08% in the last 24 hours and up +263.61% over the past month.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
See More
Previous Close:
$2.40
Open:
$2.41
24h Volume:
853.86K
Relative Volume:
0.07
Market Cap:
$88.52M
Revenue:
-
Net Income/Loss:
$-20.34M
P/E Ratio:
-3.6872
EPS:
-0.697
Net Cash Flow:
$-15.59M
1W Performance:
+5.33%
1M Performance:
+263.61%
6M Performance:
+99.22%
1Y Performance:
+9.36%
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BEAT
Heartbeam Inc
|
2.57 | 82.66M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
220.28 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.71 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.82 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.93 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.93 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-08-25 | Initiated | H.C. Wainwright | Buy |
| Oct-31-25 | Initiated | Roth Capital | Buy |
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Major HeartBeam Investor Makes Bold Move With Eye-Catching Stock Sale - TipRanks
Heartbeam Insider Sold Shares Worth $895,000, According to a Recent SEC Filing - marketscreener.com
Earnings Beat: How institutional buying supports Alector Inc stock2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will HeartBeam Inc. stock deliver shareholder value2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Buyback Activity & Free Reliable Trade Execution Plans - Улправда
Is HeartBeam Inc. Equity Warrant stock safe for conservative investors2025 Bull vs Bear & AI Forecast for Swing Trade Picks - Улправда
How HeartBeam Inc. stock performs in stagflation2025 Volatility Report & Low Risk Investment Opportunities - Улправда
Trend Report: Will HeartBeam Inc. stock deliver shareholder valueMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Can HeartBeam Inc. stock double in next 5 yearsWeekly Profit Recap & Step-by-Step Trade Execution Guides - Улправда
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Bull vs Bear & Free Community Consensus Stock Picks - Улправда
Patterns Watch: Can HeartBeam Inc. stock hit analyst price targetsPortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru
HeartBeam Director George de Urioste Sells All Common Stock Holdings - TradingView — Track All Markets
How risky is HeartBeam Inc. Equity Warrant stock nowJuly 2025 Decliners & Expert Verified Movement Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - Улправда
How institutional buying supports HeartBeam Inc. Equity Warrant stockPrice Action & High Accuracy Investment Signals - Улправда
Why HeartBeam Inc. Equity Warrant stock is a must watch in 2025Gap Up & Daily Entry Point Trade Alerts - DonanımHaber
Is HeartBeam Inc. stock dividend yield sustainable2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
What sentiment indicators say about HeartBeam Inc. stockJuly 2025 Reactions & Entry Point Confirmation Signals - DonanımHaber
Will HeartBeam Inc. Equity Warrant stock deliver consistent dividendsWeekly Profit Summary & Stepwise Trade Signal Guides - DonanımHaber
How HeartBeam Inc. stock performs in interest rate cyclesTrade Exit Summary & Smart Money Movement Tracker - DonanımHaber
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - The Globe and Mail
HeartBeam (BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - NewMediaWire
HeartBeam (NASDAQ: BEAT) ranks second worldwide in 12-lead ECG innovation - MSN
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Market Trend Summary & Precise Trade Entry Recommendations - Улправда
Rate Cut: How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsMarket Volume Report & Capital Protection Trade Alerts - Улправда
Analyst Downgrade: How institutional buying supports HeartBeam Inc. Equity Warrant stock2025 Valuation Update & Detailed Earnings Play Alerts - Улправда
ETFs Investing in Heartbeam, Inc. Stocks - TradingView — Track All Markets
HeartBeam Shares Tumble: Road to Recovery? - StocksToTrade
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - FinancialContent
HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025) - ts2.tech
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software - Diagnostic and Interventional Cardiology
HeartBeam Stock Surges 388%, With A 9-Day Winning Spree - Trefis
HeartBeam’s Stock Soars After FDA Clearance for Innovative ECG Technology - StocksToTrade
HeartBeam Stock Surges 273%, With A 8-Day Winning Spree - Trefis
HeartBeam Stock 7-Day Winning Spree: Stock Climbs 227% - Trefis
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com
HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com
HeartBeam Stock Soars: Should You Buy? - timothysykes.com
symbol__ Stock Quote Price and Forecast - CNN
Heartbeam stock is a buy, this analyst says - Cantech Letter
HeartBeam Stock Surges 201%, With A 6-Day Winning Spree - Trefis
Benchmark Upgrades HeartBeam (BEAT) - Nasdaq
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):